Glp1 Peptide GLP-1, scientifically known as glucagon-like peptide-1, is a crucial hormone naturally produced in the body that plays a significant role in regulating blood sugar and appetite. This peptide, primarily secreted by the small intestine after a meal, is central to how our bodies manage glucose levels and signal feelings of fullness. Its importance has led to the development of GLP-1 receptor agonists, a class of medications that mimic its actions, proving highly effective in managing type 2 diabetes and, more recently, in promoting weight loss.
Peptide GLP-1 is a 30- or 31-amino-acid-long peptide hormone derived from the post-translational processing of proglucagon. Its primary functions include stimulating glucose-dependent insulin secretion from the pancreas, slowing down gastric emptying (which helps in feeling full for longer), and suppressing glucagon release. These actions collectively contribute to better blood glucose control after eating.Glucagon-Like Peptide 1, Glucose-Dependent ... Beyond its metabolic effects, GLP-1 also influences satiety, reducing food intake and promoting a feeling of fullnessWHO Guideline on GLP-1 Therapies for Obesity in Adults.
The body naturally produces GLP-1, but its effects are short-lived due to rapid degradation by an enzyme called dipeptidyl peptidase-4 (DPP-4). This limited natural presence has driven research into ways to harness its benefits more effectively.
The therapeutic potential of peptide GLP-1 has been realized through the development of GLP-1 receptor agonists2025年2月23日—This genetic study revealed thatGLP-1 receptor agonists reduce weightby reducing more fat mass than muscle mass.. These medications are designed to mimic the actions of the natural hormone but are engineered for a longer duration of action.
* Diabetes Management: Initially developed for type 2 diabetes, GLP-1 receptor agonists have demonstrated high efficacy in lowering blood sugar levels and improving insulin sensitivity. They offer a significant advantage by being glucose-dependent, meaning they primarily stimulate insulin release when blood sugar is high, thus reducing the risk of hypoglycemia.
* Weight Loss: More recently, GLP-1 receptor agonists have gained considerable attention for their potent weight loss effectsA peptide triple agonist of GLP-1, neuropeptide Y1, and .... By enhancing satiety and reducing appetite, these drugs can lead to significant reductions in body weight. Studies have shown that these agonists reduce more fat mass than muscle mass, contributing to a healthier body composition.
* Oral Formulations: While many GLP-1 therapies are administered via injection, research is advancing oral small-molecule GLP-1 receptor agonists. These newer developments aim to mitigate some limitations of peptide-based therapies while retaining their beneficial properties, potentially offering greater convenience for patients.Glucagon-Like Peptide-1(GLP-1) Agonists - Singapore
Several GLP-1 analogs have been developed and approved for therapeutic use. For instance, Liraglutide is an acylated GLP-1 analog approved for once-daily use, known for its efficacy in both diabetes management and weight loss. The introduction of these analogs has revolutionized treatment options, offering more effective and targeted approaches作者：J Lau·2015·被引用次数：1124—Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analogue that binds to serum albumin in vivo and is approved for once-daily ....
Emerging therapies are also exploring dual agonism, targeting both GLP-1 and other gut hormones like GIP (glucose-dependent insulinotropic polypeptide). These advanced agonists, such as CagriSema and retatrutide, show promise for even greater weight loss, potentially doubling the results seen with current treatments by targeting multiple hormonal pathways involved in appetite and metabolism.
While medications offer a powerful way to leverage GLP-1's benefits, there's also interest in naturally increasing GLP-1 levels. Certain foods and supplements may play a role in boosting endogenous GLP-1. This approach could offer a complementary strategy for weight management and blood sugar regulation without the need for pharmaceutical intervention, though its efficacy and impact are typically less pronounced than that of pharmacologic agonists.
Despite their significant benefits, GLP-1 receptor agonists are not without potential side effects. Common side effects can include gastrointestinal issues such as nausea, vomiting, and diarrhea. More serious concerns, though rare, have been raised regarding acute pancreatitis, including necrotizing and fatal cases, prompting strengthened warnings from regulatory bodies. The FDA has also issued warnings regarding unapproved drugs containing potent GLP-1 compounds like semaglutide, tirzepatide, or retatrutide, often falsely labeled for research purposes, highlighting the importance of obtaining these medications through legitimate medical channels二肽基肽酶IV(DPP IV)是胰高血糖素样肽(GLP-1)、胰岛素刺激激素和葡萄糖依赖性胰岛素释放肽(GIP)的调节剂。它是治疗2型糖尿病(T2DM)的重要靶点。.
In conclusion, peptide GLP-1 is a vital hormone with profound implications for metabolic health.Gut Peptide GLP-1 and Its Analogue, Exendin-4, Decrease ... The development of GLP-1 receptor agonists has provided powerful tools for managing type 2 diabetes and obesity, with ongoing research promising even more advanced and accessible therapies in the future. Understanding the science behind GLP-1 and its analogs is key to appreciating their role in modern medicine.
Join the newsletter to receive news, updates, new products and freebies in your inbox.